Skip to content

Comparison of Quality of Recovery (QoR)-15 Scores Between Propofol and Remimazolam Anesthesia

Comparison of Quality of Recovery (QoR)-15 Scores According to the Use of Anesthetics During Total Intravenous Anesthesia in Female Patients Undergoing Thyroid Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05016518
Enrollment
140
Registered
2021-08-23
Start date
2021-09-16
Completion date
2022-05-20
Last updated
2022-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Thyroid Surgery for Neoplasm

Brief summary

Remimazolam is a ultra-short-acting benzodiazepine that is rapidly metabolized in the body by tissue esterase and not accumulates in the body for long periods of infusion. In addition, similar to other benzodiazepines, it is possible to reverse the sedation and anesthetic effects through flumazenil. It has no injection pain and infusion syndrome compared with propofol. There is no study to investigate overall postoperative functional recovery via QoR-15 in patients receiving TIVA using remimazolam. The purpose of this study is to determine whether there is any difference in the quality of postoperative recovery between propofol-based and remimazolam-based total intravenous anesthesia in female patients undergoing thyroidectomy. The QoR-15 questionnaire score, pain, nausea/vomiting, and the frequency of complications are evaluated and compared between the two groups.

Interventions

DRUGArm I (Propofol group)

Propfol group will be started and maintained total intravenous anesthesia with propofol and remifentanil .

DRUGArm II (Remimazolam group)

Remimazolam group will be started and maintained total intravenous anesthesia with remimazolam and remifentanil.

Sponsors

Gangnam Severance Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

•20≤Age≤65 female Open thyroidectomy ASA-PS I-III

Exclusion criteria

* Allergic history of any study drug * Taking any sedative, opioid, or sleep aid drugs * Psychiatric or neurological disorder * BMI\>30 kg/m2 * Pregnancy * Vulnerable patients

Design outcomes

Primary

MeasureTime frameDescription
postoperative day 1(POD1) Quality of Recovery(QoR)-15 questionnaire scorePostoperative day 1Quality of life will be evaluated using Quality of Recovery(QoR)-15 questionnaire score at postoperative day 1(minimum value : 0, maximum value : 150, the higher the score, the better the result)

Secondary

MeasureTime frameDescription
hospital staypreoperative - until discharge (usually 48 hours to 72hours)days of hospital stay
postoperative complicationspreoperative - until discharge (usually 48 hours to 72hours)postoperative complications
postoperative day 2(POD2) Quality of Recovery(QoR)-15 questionnaire scorePostoperative day 2Quality of life will be evaluated using Quality of Recovery(QoR)-15 questionnaire score at postoperative day 2(minimum value : 0, maximum value : 150, the higher the score, the better the result)
Response timeperioperative - until 48hoursTime from cessation of main anaesthetics to patients' response to verbal command
Tracheal extubation timeperioperative - until 48hoursTime from cessation of main anaesthetics to tracheal extubation
the incidence of administration of postoperative rescue drugperioperative - until 72hoursadministration of analgesic drug and anti-emetic drug for postoperative management
PACU(post-anesthesia care unit) stay timeperioperative - until 48hoursfrom entry of PACU to go general ward
Postoperative pain scoreat admission to PACU, discharge from PACU, postoperative 6hourspostoperative pain score measured by 11-point NRS(numerical rating scale) score (minimum : 0, maximum : 11, the lower the score, the lesser pain)
Postoperative nausea and vomitingat admission to PACU, discharge from PACU, postoperative 6hourspostoperative nausea and vomiting will be evaluated using 2 point scale (yes, no) at admission to PACU, discharge from PACU, postoperative 6hours
Postoperative sedation scoreat admission to PACU, discharge from PACUmonitored through the sedation scale called Richmond Agitation-Sedation Scale(RASS). RASS is a medical scale used to measure the agitation or sedation level of a person.The score ranges from +4 combative to -5 unarousable.
Time to recovery of self respirationperioperative - until 48hoursTime from cessation of main anaesthetics to recovery of spontaneous breathing

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026